Effect of Ondansetron in Pain and Nausea

Phase 3

• Conditions: Pain, nausea and discomfort from nasal-gastric tube insertion.

• Registration Number: IRCT20180717040509N5
• Lead Sponsor: Mazandaran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 30 November 2020

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 46

Inclusion Criteria

Patients with NG tube Indication

Exclusion Criteria

less than 18 years old
Unconsciousness
Patients with unstable hemodynamic status (systolic blood pressure less than 90 mmHg)
Having a nose bleed
Anatomical problems in the nose
Traumatic patients
Sensitivity to Ondansetron
Use of Ondansetron interfering drugs (anticholinergic, digoxin, levodopa, tetracycline)
Pregnancy
Patients with nausea and vomiting problem
NG tube more than twice

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pain, nausea and discomfort. Timepoint: Immediately, 30 and 60 minutes after NG tube insertion. Method of measurement: Visual Analgesic Score.

Secondary Outcome Measures

Name	Time	Method
Bleeding and vomiting after NG tube insertion. Timepoint: Immediately, 30 and 60 minutes after NG tube placement. Method of measurement: Visual Analgesic Score.